![Gustav von Schulthess](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Gustav von Schulthess
Entité | Type d'entité | Industrie | |
---|---|---|---|
Nuclidium AG
![]() Nuclidium AG Miscellaneous Commercial ServicesCommercial Services Nuclidium AG is a private company located in Switzerland that is revolutionizing precision oncology by developing copper-based radiopharmaceuticals for targeted cancer treatment and diagnosis. The Swiss company's product portfolio utilizes the unique properties of copper to achieve improved safety and efficacy with advantageous economics for hospitals and patients. The company overcomes supply limitations in manufacturing and distribution, bringing greater flexibility to medical facilities. Nuclidium's diverse and interdisciplinary team is focused on changing precision radio-oncology for the better to deliver a true benefit to cancer patients. The company's flexible CutraCeTM platform combines copper radiometals with highly specific cancer-targeting molecules to rapidly develop novel diagnostic and therapeutic programs. Nuclidium's differentiated "diagnostic to therapeutic" approach de-risks their development pathway.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gustav von Schulthess via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
JFG Life Sciences Stiftung der Universität Basel
![]() JFG Life Sciences Stiftung der Universität Basel Investment Trusts/Mutual FundsMiscellaneous JFG Life Sciences Stiftung der Universität Basel engages in the promotion of innovation transfer in the field of life sciences and related areas. It also supports knowledge and technology transfer at the University of Basel. The company was founded on December 20, 2018 and is headquartered Basel, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member | |
Swiss Nuclides AG
![]() Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Swiss Nuclides AG provides diagnostics and radiopharmaceutical therapy treatment services for cancer patients. The company is based in Aarau, Switzerland. The Swiss company was founded by Leila Jaafar-Thiel and Gustav von Schulthess, and Leila Jaafar-Thiel has been the CEO since incorporation. | Hospital/Nursing Management | Chief Executive Officer |
Statistiques
Internationale
Suisse | 3 |
Sectorielle
Miscellaneous | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Corporate Secretary | 1 |
Independent Dir/Board Member | 1 |
Relations les plus connectées
Insiders | |
---|---|
Matthias Staehelin | 2 |
Leila Jaafar-Thiel | 2 |
- Bourse
- Insiders
- Gustav von Schulthess
- Connexions Sociétés